Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + fentanyl versus midazolam + fentanyl for sedation during phacoemulsification cataract surgery
IRCT20180416039326N3Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of dexmedetomidine, fentanyl and midazolam in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Sedation level. Started Jun 2017; status: completed.
02
Drugs
dexmedetomidinefentanylmidazolam
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20180416039326N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N3.